Reports for SANDOZ CANADA INCORPORATED
Formerly known as NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
SANDOZ CANADA INCORPORATED
Shortage reports
Actual shortage:
51 (2%)
Anticipated shortage:
9 (0%)
Avoided shortage:
19 (1%)
Resolved:
2046 (96%)
2125
Discontinuation Reports
To be discontinued:
1 (1%)
Discontinued:
98 (97%)
Reversed:
2 (2%)
101
444 (20%)
39 (64%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ D-FORTE | 50000UNIT | CAPSULE | Resolved | 2023-07-04 | 2024-04-03 | 197064 |
| SANDOZ D-FORTE | 50000UNIT | CAPSULE | Resolved | 2022-02-24 | 2022-03-11 | 155505 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Actual shortage | 2025-05-05 | 2025-05-06 | 256661 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-08-21 | 2023-11-13 | 202538 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-09-05 | 2023-10-17 | 203653 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-11-20 | 2024-01-17 | 210838 |
| SANDOZ DAPAGLIFLOZIN | 5MG | TABLET | Resolved | 2023-12-19 | 2024-01-04 | 213801 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-01-16 | 2024-02-06 | 216168 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-03-05 | 2024-05-14 | 221380 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-07-02 | 2024-08-13 | 231744 |
| SANDOZ DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Resolved | 2021-12-30 | 2022-01-18 | 151976 |
| SANDOZ DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Resolved | 2020-01-08 | 2020-03-30 | 102568 |
| SANDOZ DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2023-06-05 | 2023-10-24 | 193710 |
| SANDOZ DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Resolved | 2023-09-19 | 2023-11-14 | 204727 |
| SANDOZ DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2022-02-17 | 2022-02-25 | 155256 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-04-23 | 2024-06-26 | 225962 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-11-25 | 2025-04-22 | 243843 |
| SANDOZ DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2025-01-13 | 2025-04-22 | 247593 |
| SANDOZ DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2025-04-07 | 2025-04-22 | 254335 |
| SANDOZ DICLOFENAC OPHTHA | 0.1% | SOLUTION | Resolved | 2022-06-03 | 2022-06-09 | 161791 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |